Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

BACKGROUND/OBJECTIVE: Delays in times to surgery, chemotherapy, and radiotherapy impair survival in breast cancer patients. Neoadjuvant chemotherapy (NAC) confers equivalent survival to adjuvant chemotherapy (AC), but it remains unknown which approach facilitates faster initiation and completion of...

Descripción completa

Detalles Bibliográficos
Autores principales: Melchior, Nicole M., Sachs, Darren B., Gauvin, Gabrielle, Chang, Cecilia, Wang, Chihsiung E., Sigurdson, Elin R., Daly, John M., Aggon, Allison A., Hayes, Shelly B., Obeid, Elias I., Bleicher, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163083/
https://www.ncbi.nlm.nih.gov/pubmed/32096915
http://dx.doi.org/10.1002/cam4.2912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163083/
https://www.ncbi.nlm.nih.gov/pubmed/32096915
http://dx.doi.org/10.1002/cam4.2912

Ejemplares similares